| 000 | 01435 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515104534.0 | ||
| 264 | 0 | _c20100304 | |
| 008 | 201003s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Pin-liang | |
| 245 | 0 | 0 |
_a[Analysis of therapeutic efficacy in 49 patients with advanced non-small cell cancer treated with gefitinib]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cAug 2007 |
||
| 300 |
_a635-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aExanthema _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aChen, Li | |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 29 _gno. 8 _gp. 635-6 |
|
| 999 |
_c17718493 _d17718493 |
||